Speed Medical results, Q1 2023
Net profit, assets, equity and cash flow for Q1 2023, against the same period a year earlier, from the published financial statements.
Net profit-24.18 millionEGP · +37.0% vs the same period a year earlier
Total assets589 millionEGP · −17.2% vs the same period a year earlier
Shareholders' equity257 millionEGP · −33.6% vs the same period a year earlier
Operating cash flow17.72 millionEGP · +553.4% vs the same period a year earlier
In short
- Speed Medical's net profit for Q1 2023 was about -24.18 million EGP, up +37.0% from -38.41 million EGP in Q1 2022.
- Total assets at the end of Q1 2023 were about 589 million EGP, and shareholders' equity about 257 million EGP.
- Operating cash flow for Q1 2023 was positive at 17.72 million EGP.
Key lines against the same period a year earlier
This periodQ1 2022Change
Net profit-24.18 million-38.41 million+37.0%
Gross profit-1.03 million31.05 million−103.3%
Total assets589 million711 million−17.2%
Total liabilities331 million324 million+2.3%
Shareholders' equity257 million388 million−33.6%
Total liabilities and equity589 million711 million−17.2%
Operating cash flow17.72 million-3.91 million+553.4%
Investing cash flow-3.82 million-39.13 million+90.2%
Financing cash flow-13.49 million-49.1 million+72.5%
Net change in cash410 thousand-92.14 million+100.4%
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.
Speed Medical's Q2 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy